NCAN and metabolic dysfunction-associated steatotic liver disease: After FDR correction, neurocan core proteins (CSPG3), cartilage intermediate layer protein 2 (CILP2), Apolipoprotein E (Apo-E), and glucokinase regulatory protein (GCKR) were found to be associated with NAFLD (PFDR < 0.05).